Iya Khalil

Digital

In a post-BIO virtual interview, Jonah Comstock speaks with Iya Khalil, VP and head of data, AI, and genome sciences at Merck & Co (MSD in Europe).

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.